[go: up one dir, main page]

ES541505A0 - Un procedimiento para la preparacion de monohidrato de bis- hidrobromuro de ceftazidima cristalino - Google Patents

Un procedimiento para la preparacion de monohidrato de bis- hidrobromuro de ceftazidima cristalino

Info

Publication number
ES541505A0
ES541505A0 ES541505A ES541505A ES541505A0 ES 541505 A0 ES541505 A0 ES 541505A0 ES 541505 A ES541505 A ES 541505A ES 541505 A ES541505 A ES 541505A ES 541505 A0 ES541505 A0 ES 541505A0
Authority
ES
Spain
Prior art keywords
ceftazidyme
crystalline
bis
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES541505A
Other languages
English (en)
Other versions
ES8606358A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES541505A0 publication Critical patent/ES541505A0/es
Publication of ES8606358A1 publication Critical patent/ES8606358A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES541505A 1984-03-26 1985-03-22 Un procedimiento para la preparacion de monohidrato de bis- hidrobromuro de ceftazidima cristalino Expired ES8606358A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/593,441 US4537959A (en) 1984-03-26 1984-03-26 Crystalline cephalosporin antibiotic salt

Publications (2)

Publication Number Publication Date
ES541505A0 true ES541505A0 (es) 1986-04-16
ES8606358A1 ES8606358A1 (es) 1986-04-16

Family

ID=24374724

Family Applications (1)

Application Number Title Priority Date Filing Date
ES541505A Expired ES8606358A1 (es) 1984-03-26 1985-03-22 Un procedimiento para la preparacion de monohidrato de bis- hidrobromuro de ceftazidima cristalino

Country Status (16)

Country Link
US (1) US4537959A (es)
EP (1) EP0157538A3 (es)
JP (1) JPS60215689A (es)
KR (1) KR870000829B1 (es)
AU (1) AU575137B2 (es)
CA (1) CA1228851A (es)
DK (1) DK131785A (es)
ES (1) ES8606358A1 (es)
GR (1) GR850708B (es)
HU (1) HU194253B (es)
IL (1) IL74671A0 (es)
NZ (1) NZ211509A (es)
PH (1) PH21943A (es)
PT (1) PT80133B (es)
SU (1) SU1356963A3 (es)
ZA (1) ZA852042B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
GB8406218D0 (en) * 1984-03-09 1984-04-11 Glaxo Group Ltd Process
US4616080A (en) * 1984-07-02 1986-10-07 Eli Lilly And Company Simplified process of forming crystalline ceftazidime pentahydrate
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US4954624A (en) * 1986-10-07 1990-09-04 Sandoz Ltd. Process for the production of cephalosporin derivatives
AT387390B (de) * 1986-10-07 1989-01-10 Biochemie Gmbh Verfahren zur herstellung des antibiotikums (6r,7r)-7-(2-(2-amino-4-thiazolyl)-2-(2-carboxy
US5021564A (en) * 1987-02-02 1991-06-04 Eli Lilly And Company Process for preparing ceftazidime pentahydrate
DE3706020A1 (de) * 1987-02-25 1988-09-08 Hoechst Ag Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung
EP0321562B1 (en) * 1987-06-25 1993-11-24 Banyu Pharmaceutical Co., Ltd. Crystalline cephalosporin compounds, process for their preparation, and intermediates for their preparation
GB8802622D0 (en) * 1988-02-05 1988-03-02 Glaxo Group Ltd Chemical compound
DE10158488A1 (de) 2001-11-28 2003-06-12 Wolff Cellulosics Gmbh & Co Kg Lösungsverzögerte Celluloseether und ein Verfahren zu ihrer Herstellung
CN102924483B (zh) * 2012-10-31 2015-06-17 海南合瑞制药股份有限公司 一种头孢他啶晶体化合物、其制备方法及其无菌混合粉形式的药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR229883A1 (es) * 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
US4329453A (en) * 1979-10-02 1982-05-11 Glaxo Group Limited Cephalosporin antibiotic
NL8005439A (nl) * 1979-10-02 1981-04-06 Glaxo Group Ltd Verbeteringen aan of met betrekking tot een cefalosporine met antibiotische werking.
DE3313816A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim

Also Published As

Publication number Publication date
EP0157538A3 (en) 1986-10-08
HU194253B (en) 1988-01-28
NZ211509A (en) 1987-11-27
AU4025085A (en) 1985-10-03
CA1228851A (en) 1987-11-03
GR850708B (es) 1985-07-19
JPS60215689A (ja) 1985-10-29
DK131785A (da) 1985-09-27
IL74671A0 (en) 1985-06-30
KR850006425A (ko) 1985-10-05
PT80133A (en) 1985-04-01
SU1356963A3 (ru) 1987-11-30
PT80133B (en) 1987-03-23
HUT36798A (en) 1985-10-28
EP0157538A2 (en) 1985-10-09
AU575137B2 (en) 1988-07-21
KR870000829B1 (ko) 1987-04-23
US4537959A (en) 1985-08-27
ES8606358A1 (es) 1986-04-16
ZA852042B (en) 1986-10-29
PH21943A (en) 1988-04-15
DK131785D0 (da) 1985-03-22

Similar Documents

Publication Publication Date Title
ES540366A0 (es) Un procedimiento para la preparacion de un compuesto
ES547840A0 (es) Un procedimiento para la preparacion de alquilsulfonamidofe-nilalquilaminas
ES548430A0 (es) Un procedimiento para la preparacion de nuevos derivados de carbazolona
ES557126A0 (es) Un procedimiento para la preparacion de triazolobenzodiazepinas
ES557051A0 (es) Un procedimiento para la preparacion de derivados de cefalosporina
ES556786A0 (es) Un procedimiento para la preparacion de derivados de cefalosporina
ES554609A0 (es) Un procedimiento para la preparacion de derivados de oxindol
ES541505A0 (es) Un procedimiento para la preparacion de monohidrato de bis- hidrobromuro de ceftazidima cristalino
ES551552A0 (es) Un procedimiento para la preparacion de nuevos compuestos de sulfonilurea
ES548033A0 (es) Un procedimiento para la preparacion de nuevos derivados pe-nem
ES540200A0 (es) Un procedimiento para la preparacion de acidos 7-amino-3-me-til sustituido-3-defem-4-carboxilicos
ES544970A0 (es) Un procedimiento para la preparacion de derivados de benzo- tiofeno
ES538019A0 (es) Un procedimiento para la preparacion de monohidrato de hidrocloruro de cefalexina cristalino
ES545298A0 (es) Un procedimiento para la preparacion de 4-amino-2-fenilqui- nolinas
ES542613A0 (es) Un procedimiento para la preparacion de compuesto denominado cl-1724b-2
ES551755A0 (es) Un procedimiento para la preparacion de derivados de d4-y-d5-androsteno nuevos
ES541373A0 (es) Un procedimiento para la preparacion de un compuesto de 2-oxindol-1-carboxamida
ES548960A0 (es) Un procedimiento para la preparacion de derivados de hidan- toina
ES557267A0 (es) Un procedimiento para la preparacion de derivados amidinofenilicos
ES542517A0 (es) Un procedimiento para la preparacion de monoalquil-polial- quilenpoliaminas
ES548147A0 (es) Un procedimiento para la preparacion de nuevos derivados pe-nem
ES544397A0 (es) Un procedimiento para la preparacion de un compuesto
ES542674A0 (es) Un procedimiento para la preparacion de compuestos de cefa- losporina
ES553605A0 (es) Un procedimiento para la preparacion de derivados de carbpenem
ES552986A0 (es) Un procedimiento para la preparacion de piridazinilimidazolidinonas